BrayneC. (1993) Clinicopathological studies of the dementias from an epidemiological viewpoint. British Journal of Psychiatry162: 439–446.
2.
BrayneC.CallowayP. (1988) Is Alzheimer’s disease distinct from normal ageing?Lancet332: 514–515.
3.
BrayneC.DavisD. (2012) Making Alzheimer’s and dementia research fit for populations. Lancet380: 1441–1443.
4.
Christa Maree StephanB.MinettT.PagettE.SiervoM.BrayneC.McKeithI. G. (2013) Diagnosing mild cognitive impairment (MCI) in clinical trials: A systematic review. BMJ Open3: e001909.
5.
HuppertF. A.BrayneC.O’ConnorD. W. (1994) Dementia and normal aging, Cambridge, UK: Cambridge University Press.
6.
Le CouteurD. G.DoustJ.CreaseyH.BrayneC. (2013) Political drive to screen for pre- dementia: Not evidence based and ignores the harms of diagnosis. BMJ (Clinical Research Ed.)347: f5125.
7.
MatthewsF. E.StephanB. C.McKeithI. G.BondJ.BrayneC.Medical Research Council Cognitive Function, Ageing Study (2008) Two-year progression from mild cognitive impairment to dementia: To what extent do different definitions agree?Journal of the American Geriatrics Society56: 1424–1423.
8.
RichardsM.BrayneC. (2010) What do we mean by Alzheimer’s disease?BMJ341: c4670.
9.
WrightC. F.HallA.MatthewsF. E.BrayneC. (2009) Biomarkers, dementia, and public health. Annals of the New York Academy of Sciences1180: 11–19. doi: 10.1111/j.1749-6632.2009.04942.
